Ledger.Open graph →

SEC Form D · filed January 16, 2025

Rivus Pharmaceuticals, Inc

Offering

$57.0M

Sold

$57.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

CHARLOTTESVILLE, VA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Shaharyar Khan · Charlottesville, VAExec · Director Rick Winningham · Charlottesville, VADirector Allen Cunningham · Charlottesville, VAExec · Director Jayson Dallas · Charlottesville, VAExec · Director Robert Schott · Charlottesville, VAExec Tom O'Neil · Charlottesville, VAExec Derek Dirocco · South San Francisco, CADirector Ian Smith · New York, NYDirector Erin Lavelle · Redmond, WADirector Francesco De Rubertis · BRIGHTON, MADirector Robert Schott · Charlottesville, VAExec Shaharyar Khan · Charlottesville, VAExec · Director Rick Winningham · Charlottesville, VADirector Allen Cunningham · Charlottesville, VAExec · Director Jayson Dallas · Charlottesville, VAExec · Director Tom O'Neil · Charlottesville, VAExec Derek Dirocco · South San Francisco, CADirector Ian Smith · Windermere, FLDirector Erin Lavelle · Redmond, WADirector Francesco De Rubertis · ST HELIER, Y9Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗